CBT
Cabot Corp
NYSE · Chemicals
$74.58
-1.67 (-2.19%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 3.58B | 3.76B | 183.52M | 185.80M | 154.67M |
| Net Income | 318.92M | 301.91M | 14.93M | 14.53M | 13.23M |
| EPS | — | — | — | — | — |
| Profit Margin | 8.9% | 8.5% | 8.1% | 7.8% | 8.6% |
| Rev Growth | -4.9% | -4.9% | +20.7% | +7.5% | +12.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 821.06M | 821.06M | 693.97M | 777.42M | 779.25M |
| Total Equity | 1.13B | 1.13B | 2.37B | 2.58B | 2.20B |
| D/E Ratio | 0.73 | 0.73 | 0.29 | 0.30 | 0.35 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 739.96M | 739.42M | 25.81M | 24.94M | 19.49M |
| Free Cash Flow | — | — | 11.29M | 7.01M | 6.93M |